Research Intelligence & Discovery - software & AI news

Daily news on software, AI, and companies shaping research intelligence & discovery.

Showing 51 results
Press release cover image

Nov 3, 2026

How the NIH Common Fund Data Ecosystem Could Accelerate Scientific Discovery

CU Anschutz researchers play a major role in evaluating research data from 18 programs to help scientists uncover relationships across studies and make better use of existing research.AURORA, Colo., Nov. 3, 2026 /PRNewswire/ -- Scientists generate vast amounts of research data, but connecting information across studies can be difficult. The NIH Common Fund Data Ecosystem is working to change that by making research datasets from 18 NIH programs easier to find, connect and analyze.The initiative
A magnifying glass over a grid pattern representing data analysis in healthcare.

Oct 27, 2026

Q&A: Google on using AI to detect healthcare bias, accelerate discovery

In a recent discussion at the HIMSS AI Forum, Aashima Gupta, Google's global director of healthcare, explored the potential of AI to mitigate bias in healthcare and enhance scientific discovery.Gupta emphasized that bias is ingrained in healthcare data due to historical inequities, highlighting AI's role in identifying these patterns. For instance, AI can flag instances where care is disproportionately directed towards specific populations, prompting healthcare professionals to reassess their pr
Minimalist illustration of a brain atlas and cellular shapes

Oct 22, 2026

PerturbAI and OpenAI Launch AI Reasoning Agents for Biomedical Discovery

PerturbAI and OpenAI have unveiled a groundbreaking AI reasoning framework designed to enhance biomedical discovery by enabling scientists to efficiently analyze large datasets and formulate testable hypotheses.The collaboration, which includes contributions from researchers at Scripps Research Institute, UC San Diego, and Howard Hughes Medical Institute, focuses on the application of this AI framework to PerturbAI’s recently published whole-brain atlas. By deploying thousands of AI agents, the
Press release cover image

Oct 22, 2026

Phylo's Biomni Lab to expand the use of AI agents in scientific research at Bayer

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 /PRNewswire/ -- Phylo, Inc. announced today a partnership with Bayer to deploy Biomni Lab, Phylo's agentic AI platform to accelerate scientific research and evaluation. Under the agreement, Phylo will provide Bayer with full access to its agentic platform that helps Bayer scientists bring together scientific literature, biomedical data, and analytical methods in one environment, reducing the manual effort required to assemble and assess evidence. The pl
Press release cover image

Oct 21, 2026

PerturbAI and OpenAI Unveil First-of-Its-Kind AI Reasoning Agents to Scale Biomedical Discovery

- Thousands of AI agents work in parallel to interpret experimental data, connect findings with scientific literature, and identify promising hypotheses for scientists to test -- Agents analyzed PerturbAI's whole-brain genomic dataset and synthesized insights in just 32 minutes, compared with an estimated months to a year of serial human analysis and literature review -- The work builds on a year-long collaboration that is now expanding into joint drug-target discovery, leveraging PerturbAI's pr
Press release cover image

Oct 15, 2026

Elsevier Commits to Accelerate AI-Driven Science Across Europe

Commitment to the European Commission's AI in Science Enablers Initiative includes 4,000 complimentary AI product licenses, support for new research collaborations, and expanded PhD, postdoctoral, and master's training in AI-assisted researchDUBLIN, Oct. 15, 2026 /PRNewswire/ -- Elsevier, a global leader in advanced information and decision support in science and healthcare, today announced its pledge to the European Commission's AI in Science Enablers Initiative.Elsevier's contribution spans co
Press release cover image

Oct 14, 2026

INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro ™

Collaboration combines INmune Bio's clinical research with QCi's  Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XProInitial engagement marks QCi's first commercial customer in pharmaceutical and biotechnology markets, expanding the application of quantum computing to drug development BOCA RATON, Fla. and HOBOKEN, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (Nasdaq: INMB) and Quantum Computing Inc. (Nasdaq: QUBT) today anno
Press release cover image

Oct 14, 2026

Danaher Collaborates with NVIDIA to Advance Autonomous Science

Collaboration will bring together NVIDIA AI technologies and Danaher's scientific instruments, laboratory workflows and dataWASHINGTON, Oct. 14, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced a collaboration with NVIDIA to advance autonomous science and help accelerate the pace of scientific discovery. As part of Danaher's broader effort to shape the future of AI-enabled science, the companies are working to combine Danaher's scientific instrumentation, automation technolog
Press release cover image

Oct 8, 2026

Apodex Opens Free AI Computing Services to Accelerate Drug Research

Small and mid-sized drug developers gain free access to AI agents, computing power and biomedical evidenceREDWOOD CITY, Calif., Oct. 8, 2026 /PRNewswire/ -- AI has opened a new opportunity for drug research, but many small and mid-sized biotech and pharmaceutical companies cannot afford the specialized talent and computing power needed to use it. Apodex today announced that it will offer its AI drug research services to these companies free of charge, drawing on its own research team, large-scal
Press release cover image

Oct 8, 2026

Rivercell Launches With $25 Million to Build Data Platforms and AI Models That Predict How Human Cells Respond to Treatment

Founded by serial entrepreneur and CEO, Yann Fleureau, and former AI research leader at Novartis and Owkin Eric Durand, Rivercell aims to generate high-resolution data on how human cells respond to treatments at scale and train AI models to predict their effects, ultimately accelerating the discovery and development of cures.Seed round led by HV, with participation from HCVC, Alven, and Bpifrance Digital Venture, to scale Rivercell's proprietary data engine and automated wet lab, and ship the fi
Press release cover image

Oct 7, 2026

International, cross-sector collaboration commits nearly $2 billion to build foundational data for AI models to predict and treat disease

REDWOOD CITY, Calif., Oct. 7, 2026 /PRNewswire/ -- Biohub, the U.S. Department of Energy, the National Institutes of Health, and new funding partners today announced a major expansion of an international effort to generate and make accessible the data enabling predictive AI models of biology. Together, the organizations are investing $1.8 billion in funding, data, computation, and new measurement technology, the largest coordinated commitment to generating AI-ready biological data to date. The r
Press release cover image

Sep 29, 2026

Phylo Launches Target Atlas to Speed Up Target Prioritization

Hundreds of AI agents curate and synthesize evidence across thousands of target–disease assessments, with the first disease-specific application developed with The Michael J. Fox Foundation Targets to Therapies initiativeSOUTH SAN FRANCISCO, Calif., Sept. 29, 2026 /PRNewswire/ -- Phylo today launched Target Atlas, an agentic target-prioritization app built on Biomni Lab, the company's Integrated Biology Environment. Target Atlas can cut the evidence-gathering behind target reviews from months of